| Early SARS-CoV-2 outbreak detection by sewage-based epidemiology G Orive, U Lertxundi, D Barcelo Science of The Total Environment 732, 139298, 2020 | 164 | 2020 |
| Expert‐based drug lists to measure anticholinergic burden: similar names, different results U Lertxundi, S DOMINGO‐ECHABURU, R Hernandez, J Peral, J Medrano Psychogeriatrics 13 (1), 17-24, 2013 | 107 | 2013 |
| Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database. M García, MA Aranburu, I Palacios‐Zabalza, U Lertxundi, C Aguirre Journal of Clinical Pharmacy & Therapeutics 41 (3), 2016 | 99 | 2016 |
| Antipsychotics and seizures: higher risk with atypicals? U Lertxundi, R Hernandez, J Medrano, S Domingo-Echaburu, M García, ... Seizure 22 (2), 141-143, 2013 | 95 | 2013 |
| Artificial neural network-based estimation of COVID-19 case numbers and effective reproduction rate using wastewater-based epidemiology G Jiang, J Wu, J Weidhaas, X Li, Y Chen, J Mueller, J Li, M Kumar, X Zhou, ... Water research 218, 118451, 2022 | 58 | 2022 |
| Domperidone in Parkinson’s disease: a perilous arrhythmogenic or the gold standard? U Lertxundi, S Domingo-Echaburu, A Soraluce, M García, B Ruiz-Osante, ... Current drug safety 8 (1), 63-68, 2013 | 57 | 2013 |
| Correlation between SARS-CoV-2 RNA concentration in wastewater and COVID-19 cases in community: a systematic review and meta-analysis X Li, S Zhang, S Sherchan, G Orive, U Lertxundi, E Haramoto, R Honda, ... Journal of Hazardous Materials 441, 129848, 2023 | 48 | 2023 |
| Antidopaminergic therapy for managing comorbidities in patients with Parkinson’s disease U Lertxundi, J Peral, O Mora, S Domingo-Echaburu, ... American Journal of Health-System Pharmacy 65 (5), 414-419, 2008 | 44 | 2008 |
| Medication errors in Parkinson's disease inpatients in the Basque Country U Lertxundi, A Isla, MÁ Solinís, S Domingo-Echaburu, R Hernandez, ... Parkinsonism & related disorders 36, 57-62, 2017 | 41 | 2017 |
| Anticholinergic burden in Parkinson’s disease inpatients U Lertxundi, A Isla, MA Solinis, S Domingo-Echaburu, R Hernandez, ... European journal of clinical pharmacology 71, 1271-1277, 2015 | 41 | 2015 |
| Antipsychotics as environmental pollutants: an underrated threat? J Escudero, JL Muñoz, T Morera-Herreras, R Hernandez, J Medrano, ... Science of The Total Environment 769, 144634, 2021 | 40 | 2021 |
| Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicación informática J Peral Aguirregoitia, U Lertxundi Etxebarria, MJ Martínez Bengoechea, ... Farmacia Hospitalaria 31 (2), 93-100, 2007 | 37* | 2007 |
| Drug pollution & sustainable development goals S Domingo-Echaburu, LM Dávalos, G Orive, U Lertxundi Science of The Total Environment 800, 149412, 2021 | 34 | 2021 |
| Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology A Estévez-Danta, L Bijlsma, R Capela, R Cela, A Celma, F Hernández, ... Science of the Total Environment 836, 155697, 2022 | 32 | 2022 |
| SGLT2 inhibitors and bladder cancer: analysis of cases reported in the European Pharmacovigilance Database M Garcia, U Arteche‐Martinez, U Lertxundi, C Aguirre The Journal of Clinical Pharmacology 61 (2), 187-192, 2021 | 28 | 2021 |
| Environmental pollution with psychiatric drugs J Argaluza, S Domingo-Echaburu, G Orive, J Medrano, R Hernandez, ... World journal of psychiatry 11 (10), 791, 2021 | 27 | 2021 |
| Greening the pharmacy G Orive, U Lertxundi, T Brodin, P Manning Science 377 (6603), 259-260, 2022 | 26 | 2022 |
| Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database U Lertxundi, AI Ruiz, MÁS Aspiazu, S Domingo-Echaburu, M García, ... Clinical Neuropharmacology 38 (3), 69-84, 2015 | 26 | 2015 |
| Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation? U Lertxundi, R Hernandez, J Medrano, S Domingo-Echaburu, M Garcia, ... International clinical psychopharmacology 33 (1), 56-58, 2018 | 21 | 2018 |
| Estimación de la tasa de filtración glomerular para el ajuste posológico de los fármacos: reina la confusion J Peral-Aguirregoitia, U Lertxundi-Etxebarria, R Saracho-Rotaeche, ... Nefrología (Madrid) 32 (1), 115-117, 2012 | 19* | 2012 |
Gorka OriveFull Professor of Pharmacy & Pharmaceuticals Technology Networking Biomedical Research CenterVerified email at ehu.eus
